Skip to main content
. Author manuscript; available in PMC: 2013 Jul 8.
Published in final edited form as: Clin Cancer Res. 2009 Nov 17;15(23):7398–7404. doi: 10.1158/1078-0432.CCR-09-1957

Table 2.

Adverse events at least possibly related to treatment

Toxicity Grade
2 3 4 Total
Cerebrovascular ischemia 0 0 1 1
Fatigue 2 0 0 2
Gingival regression 1 0 0 1
Hypocalcemia 1 0 0 1
Orthostasis 1 0 0 1
Muscle weakness 1 0 0 1
Neuropathy, cranial 0 1 0 1
Musculoskeletal pain 2 0 0 2
Thrombosis/thrombus/embolism 0 1 0 1
Total 10 2 1 12